Dotaxol 20 mg Injection (Docetaxel) — Taxane Chemotherapy for Solid Tumours Dotaxol 20 mg Injection is a targeted taxane chemotherapy medicine containing docetaxel, used to treat a wide range of solid cancers, including advanced or metastatic breast cancer, non‑small cell lung cancer (NSCLC), prostate cancer, stomach cancer, and head & neck cancer. It works by inhibiting microtubule function during cell division, preventing cancer cells from multiplying and promoting cancer cell death. Docetaxel is given as an intravenous infusion by trained healthcare professionals in hospital or oncology settings, typically with steroid premedication to reduce hypersensitivity reactions and close monitoring of blood counts and organ functions. Common side effects include bone marrow suppression, hair loss, nausea, fatigue, fluid retention, and numbness, making clinical supervision essential.